- Intuitive Surgical has massively outperformed the S&P 500 as well as the iShares IHI and is now in the middle of a severe price correction.
- Significant growth opportunity with projected 14.67% FCF and 18.35% EBIT CAGR over the next 5 years.
- Intuitive Surgical is by far the market leader in the surgical robotic market but is facing increasing competition from companies with both massive financial resources and high innovation capacities.
- Based on my valuation model, the stock is fairly priced with a slightly higher price target at $236.
For further details see:
Intuitive Surgical Faces More Challenges